NCT03683108View on ClinicalTrials.gov

Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infancy

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Common Cold
Interventions
DRUG

Resveratrol and Carbossimetyl Beta Glucan

Medical device based on Resveratrol and Carbossimetyl Beta Glucan. 3 drops, 4 times a day for 1 week.

OTHER

Saline Solution

Medical device based on Saline Solution. 3 drops, 4 times a day for 1 week.

Trial Locations (1)

70124

Dept Of Obstetrics and Neonatology - Section of Neonatology University of Bari Policlinico Hospital, Bari

All Listed Sponsors
lead

Policlinico Hospital

OTHER

NCT03683108 - Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infancy | Biotech Hunter | Biotech Hunter